This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Singapore’s Healthway, IHC to revise acquisition terms after SGX warning

( September 17, 2015, 05:40 GMT | Official Statement) -- MLex Summary: Singaporean healthcare provider Healthway Medical said it has agreed with International Healthway Corporation, or IHC, to revise the terms of IHC's proposed acquisition of Healthway through a share swap. The announcement follows a Sept. 9 advisory from the Singapore Exchange, which warned investors that a review had found that more than 60 percent of the trades in IHC shares since April were conducted by a handful of individuals who seem to be connected to each other. Details of the revision have yet to be released. The acquisition was first announced in June.The company's full statement is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections